MedPath

安若维他药业泰州有限公司

Ownership
-
Established
2018-01-29
Employees
-
Market Cap
-
Website
http://www.aurovitas.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

NMPA:3

Drug Approvals

Perindopril tert-Butylamine Tablets

Product Name
培哚普利叔丁胺片
Approval Number
国药准字H20253778
Approval Date
Apr 1, 2025
NMPA

Perindopril tert-Butylamine Tablets

Product Name
培哚普利叔丁胺片
Approval Number
国药准字H20253777
Approval Date
Apr 1, 2025
NMPA

Perindopril tert-Butylamine Tablets

Product Name
培哚普利叔丁胺片
Approval Number
国药准字H20253776
Approval Date
Apr 1, 2025
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.